CT Innovation
VC Fund
Verona, Italy
CT Innovation is a VC fund in Verona focused on Health Care and Payments. CT Innovation offers mart collaboration, industry 4.0, digital transformation, control room, governance, lean production, workspace, meeting room, innovation, and augmented intelligence services. They offer companies technological systems for the collection, display, and management of information of various kinds, coming from different andheterogeneous systems, in order to make it easily available.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries CT Innovation invests in
Stages CT Innovation invests in
Countries CT Innovation invests in
Investment Focus
Industry
- Health Care 3 (43%)
- Payments 2 (29%)
- Information Technology 2 (29%)
- Billing 1 (14%)
- Farming 1 (14%)
Stage
- Series A 2 (29%)
- Venture - Series Unknown 2 (29%)
- Seed 1 (14%)
- Series D 1 (14%)
- Funding Round 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Inbox Health
|
Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $20M / Sep 15, 2025 | |
BloomCredit
|
Bloom Credit helps companies launch lending products, report consumers' payments, and create innovative credit experiences. We do this by providing our clients with the data they need from all three credit bureaus, the expertise they are looking for to launch seamlessly, and the proprietary analytics to supplement credit insights - alldelivered through Bloom’s developer-friendly API. With credit at the heart of financial customer relationships, BloomCredit creating advanced developer-friendly API solutions that can improve, monitor, and promote credit health to build trust between consumers and the financial institutions that serve them.It was founded in 2016 and is based in New York, United States. | $10.5M / Venture - Series Unknown / Apr 23, 2025 | |
Intellihealth
|
Intellihealth offers a clinically proven medical obesity treatment approach that is three times more effective than lifestyle intervention alone. Our flagship product, Evolve, enables medical providers to offer effective medical obesity treatment to new and existing patients, both via telehealth and in person. More information and a productdemonstration can be found at www.intellihealth.co | $24M / Series A / Mar 01, 2024 | |
Clean Crop Technologies
|
Clean Crop Technologies is translating groundbreaking research on ways to reduce molds, toxins, and pests into commercial scale services for the global grain and nut sectors. | Venture - Series Unknown / Feb 07, 2023 | |
Cambium
|
Cambium Carbon is an early stage social enterprise start up focused on implementing systems-level natural climate solutions centered on reforestation and urban wood reuse. | $3.2M / Seed / Mar 15, 2022 | |
|
Inbox Health
|
Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges. Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communicationplatform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns. | $15M / Series A / Apr 05, 2021 | |
Cara Therapeutics
|
Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patentedcompound, CR845, is currently undergoing clinical testing for acute pain and pruritis. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology. | $4.8M / Series D / May 21, 2012 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does CT Innovation invest in?
CT Innovation invests primarily in Health Care, Payments and Information Technology startups, most often at Series A and Venture - Series Unknown stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did CT Innovation last invest?
The most recent investment recorded for CT Innovation closed in Sep 2025. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
